黑色素改善生活质量,氧化压力和心血管功能在肺动脉高血压
Alicia de la Fuente1, Mónica Zagolín2, Víctor Parra1,2
1Institute of Biomedical Sciences (ICBM), Faculty of Medicine Universidad de Chile Santiago Chile.
Pulmonary circulation
|June 20, 2025
概括
黑色素治疗改善了肺动脉高血压 (PAH) 患者的生活质量和抗氧化能力. 这项试点研究表明,在六个月的时间里,症状和身体健康都有好处.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 生物化学 生物化学
背景情况:
- 肺动脉高血压 (PAH) 是一种严重的,进展性疾病,与增加的氧化压力有关.
- 氨酸是一种强大的抗氧化剂,在PAH的临床前模型中显示出有前途.
研究的目的:
- 评估6个月的黑激素治疗对1组PAH患者的功能,血液动力和抗氧化剂状况的影响.
- 评估6分钟步行距离 (6MWT),功能类 (FC),生活质量 (QoL) 和血抗氧化能力的变化.
主要方法:
- 一项为期6个月的开放标签试点研究,涉及19名稳定的1组PAH患者 (世卫组织FCII-III).
- 临床评估在基线,3个月,6个月,包括6MWT,PAH-SYMPACT问卷和血抗氧化能力的生物化学分析.
主要成果:
- 显著改善了QOL,特别是在身体领域,并减少了症状感知 (呼吸不全,心,疲劳).
- 观察到血总抗氧化剂和铁的降解能力增加.
- 听力心声学变量或6MWT距离没有显著变化.
结论:
- 口服黑激素治疗似乎可以改善PAH患者的血抗氧化能力和生活质量.
- 黑色素可能是一种有益的辅助治疗,用于控制PAH的症状和改善幸福感.
- 需要对更大的队列进行进一步的研究来证实这些发现.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
327
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
327
COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
256
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
256
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Pulmonary Hypertension: Classification and Pathogenesis
297
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
297
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
137
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
137


